Copyright
©The Author(s) 2025.
World J Hepatol. Jan 27, 2025; 17(1): 101664
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101664
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101664
Figure 3 Temporal response of eosinophil count following triclabendazole treatment in a patient with hepatic eosinophilic pleural effusion secondary to Fasciola hepatica infection.
The dynamic changes in eosinophil levels are shown. A marked reduction of eosinophil levels occurred after a single dose of triclabendazole, highlighting the efficacy of triclabendazole in the therapeutic management of parasitic hepatic eosinophilic pseudotumor.
- Citation: Le KL, Tran MQ, Pham TN, Duong NNQ, Dinh TT, Le NK. Hepatic eosinophilic pseudotumor due to Fasciola hepatica infection mimicking intrahepatic cholangiocarcinoma: A case report. World J Hepatol 2025; 17(1): 101664
- URL: https://www.wjgnet.com/1948-5182/full/v17/i1/101664.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i1.101664